Metformin, an oral anti-glycemic agent used to manage Type 2 Diabetes, Gestational Diabetes and Polycystic Ovary Syndrome, acts by inhibiting gluconeogenesis and enhancing insulin sensitivity in peripheral tissues. This evidence concerns the gene INS and polycystic ovary syndrome.